Literature DB >> 3711081

Inhibition of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate.

H J Harwood, Y J Greene, P W Stacpoole.   

Abstract

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity in microsomes isolated from cultured lymphoid (IM-9) cells or freshly isolated human leukocytes was markedly decreased by either ascorbic acid or its oxidized derivative, dehydroascorbate. Inhibition of IM-9 leukocyte HMG-CoA reductase activity was log linear between 0.01 and 10 mM ascorbic acid (25 and 81% inhibition, respectively) and 0.1 and 10 mM dehydroascorbate (5 and 75% inhibition, respectively). Inhibition was noncompetitive with respect to HMG-CoA (Km = 10.2 microM (RS); ascorbic acid, Ki = 6.4 mM; dehydroascorbate, Ki = 15 mM) and competitive with respect to NADPH (Km = 16.3 microM; acetic acid, Ki = 6.3 mM; dehydroascorbate, Ki = 3.1 mM). Ascorbic acid and dehydroascorbate are interconverted through the free radical intermediate monodehydroascorbate. Reducing agents are required to convert dehydroascorbate to monodehydroascorbate, but prevent formation of the free radical from ascorbate. In microsomes from IM-9 cells, the reducing agent, dithiothreitol, abolished HMG-CoA reductase inhibition by ascorbate but enhanced inhibition by dehydroascorbate. In addition, the concentration of monodehydroascorbate present in ascorbate solutions was directly proportional to the degree of HMG-CoA reductase inhibition by 1.0 mM ascorbate. Fifty per cent inhibition of enzyme activity occurred at a monodehydroascorbate concentration of 14 microM. These data indicate that monodehydroascorbate mediates inhibition of HMG-CoA reductase by both ascorbate and dehydroascorbate. This effect does not appear to be due to free radical-induced membrane lipid modification, however, since both ascorbate and dehydroascorbate inhibited the protease-solubilized, partially purified human liver enzyme. Since inhibition of HMG-CoA reductase occurs at physiological concentrations of ascorbic acid in the human leukocyte (0.2-1.72 mM), this vitamin may be important in the regulation of endogenous cholesterol synthesis in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711081

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Erythrocyte contamination of leukocyte populations following density-gradient centrifugation results in artificially high levels of human leukocyte HMG-CoA reductase activity.

Authors:  H J Harwood; D M Bridge; P W Stacpoole
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

2.  Two distinct uptake mechanisms for ascorbate and dehydroascorbate in human lymphoblasts and their interaction with glucose.

Authors:  F C Ngkeekwong; L L Ng
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

3.  Inhibition of dimeric dihydrodiol dehydrogenases of rabbit and pig lens by ascorbic acid.

Authors:  A Hara; M Shinoda; T Kanazu; T Nakayama; Y Deyashiki; H Sawada
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

4.  In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects.

Authors:  H J Harwood; D M Bridge; P W Stacpoole
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

Review 5.  The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q.

Authors:  R E Beyer
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

6.  Consortia of bioactives in supercritical carbon dioxide extracts of mustard and small cardamom seeds lower serum cholesterol levels in rats: new leads for hypocholesterolaemic supplements from spices.

Authors:  Soumi Chakraborty; Kaninika Paul; Priyanka Mallick; Shrabani Pradhan; Koushik Das; Saikat Chakrabarti; Dilip Kumar Nandi; Paramita Bhattacharjee
Journal:  J Nutr Sci       Date:  2019-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.